IBU (TM) IBUPROFEN Tablets, USP, 800 mg, 500 -count bottle,(NDC 55111-684-05) Rx only, Distributed by Dr. Reddy's Laboratories, Inc., Bridgewater, NJ 08807 USA.

Labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expiration date of 05/2017. The correct expiration date is 10/2016.

Recall #: D-1042-2013
Affected scope: 18852 bottles
Initiated: August 29, 2013

Compiled from official public sources by the publisher. · Updated September 2026

Verify with FDA Drug →

View my saved recalls

Dr. Reddy's Laboratories, Inc. recalled IBU (TM) IBUPROFEN Tablets, USP, 800 mg, 500 -count bottle,(NDC 55111-684-05) Rx only, Di… - a moderate-severity action.

IBU (TM) IBUPROFEN Tablets, USP, 800 mg, 500 -count bottle,(NDC 55111-684-05) Rx only, Di… was recalled by Dr. Reddy's Laboratories, Inc. in September 25, 2013. Reason: Labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expira…. Check the official notice for the remedy. Verify recall #D-1042-2013 with the FDA Drug before acting.

The recall

Dr. Reddy's Laboratories, Inc. issued this moderate-severity FDA Drug recall-Labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expira….

Moderate
severity level: Class II
classification: September 25, 2013
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-1042-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

IBU (TM) IBUPROFEN Tablets, USP, 800 mg, 500 -count bottle,(NDC 55111-684-05) Rx only, Distributed by Dr. Reddy's Laboratories, Inc., Bridgewater, NJ 08807 USA.

Reason for recall

Labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expiration date of 05/2017. The correct expiration date is 10/2016.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Moderate (Class II)
Status	Terminated
Recall number	D-1042-2013
Date reported	September 25, 2013
Date initiated	August 29, 2013
Recalling firm	Dr. Reddy's Laboratories, Inc.
Firm location	Bridgewater, NJ
Affected scope	18852 bottles
Distribution	Nationwide (& Puerto Rico)

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-1042-2013) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

IBU (TM) IBUPROFEN Tablets, USP, 800 mg, 500 -count bottle,(NDC 55111-684-05) Rx only, Distributed by Dr. Reddy's Laboratories, Inc., Bridgewater, NJ 08807 USA.. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: 18852 bottles.

Why was this product recalled? ▼

Labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expiration date of 05/2017. The correct expiration date is 10/2016.

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on September 25, 2013. Severity: Moderate. Recall number: D-1042-2013.

Where was the recalled product distributed? ▼

Distribution: Nationwide (& Puerto Rico).

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Moderate), closest by report date among other firms and states.

Votive Candle Holders Sold at Cracker Bar… 2013-09-25 Dextrose 50% Preservative Free SDV Inject… 2013-09-25 Hyaluron (hyaluronidase) 150 units/mL Pre… 2013-09-25 Bevacizumab (Avastin) 2.5mg/0.1mL PF Inj… 2013-09-25

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Lidocaine/Phenylephrine PF 1%/1.5% Inject… 2013-09-25 Acetylcysteine 20% Solution, Preservative… 2013-09-25 Sodium Thiosulfate 25%, 250 mg/mL (12.5 g… 2013-09-25 Sodium Citrate 4% containing Gentamicin 3… 2013-09-25

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported September 25, 2013. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026